Skip to main content

MoneyWorks4Me

Divis Laboratories board to consider financial results

19 Oct 2012 Evaluate
Divis Laboratories has informed that a meeting of the board of directors of the company will be held on November 03, 2012, to consider and approve, the un-audited financial results for the second quarter ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..